FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801148110> ?p ?o ?g. }

• W2801148110 endingPage "391" @default.
• W2801148110 startingPage "382" @default.
• W2801148110 abstract "Abstract Introduction Omalizumab has been available for treatment of allergic asthma for more than a decade and thus, its efficacy in routine treatment was of interest to evaluate. Basophil allergen threshold sensitivity (CD‐sens) has been shown to correlate with the bronchial allergen threshold sensitivity and can be used to objectively measure omalizumab treatment efficacy. We aimed to evaluate the effect of omalizumab treatment of allergic asthma by CD‐sens, as an objective marker of the IgE‐mediated inflammation, and related to SPT, spirometry, FeNO, Asthma Control Questionnaire (ACQ), and Global Evaluation of Treatment Effectiveness (GETE). Methods Thirty‐two patients were treated with omalizumab for 16 weeks. CD‐sens was used to define the response and related to clinical parameters. If CD‐sens was negative (<0.1) (CD‐sens low Group) the patient continued with the standard dose. If CD‐sens was ≥0.1 (CD‐sens high Group) a second 16 weeks period with 25–50% dosage increase was started and evaluated after a total of 32 weeks. Results Nine of 32 patients became CD‐sens negative after treatment (CD‐sens start: 8.0; 16 weeks: <0.01) and regarded as successful. 15/23 were unsuccessful (CD‐sens start: 13; 16 weeks: 1.65) and the omalizumab dose was increased. CD‐sens decreased significantly ( p < 0.05) and further 3/15 patients became CD‐sens negative (CD‐sens at 32 weeks: 0.5). There was a significantly smaller IgE‐ab fraction (IgE‐ab/IgE) in the CD‐sens low versus the CD‐sens high Group ( p < 0.0001). A significant decrease in ACQ was seen in both groups after 16 weeks treatment ( p = 0.05 and 0.01, respectively). No significant changes could be detected for the other clinical parameters. Conclusion By the use of the objective laboratory method CD‐sens, which effectively measure the direct effect of omalizumab, that is, the IgE‐mediated part of the allergic asthma, in combination with clinical parameters it might be possible to more effectively monitor and treat IgE‐mediated allergic asthma." @default.
• W2801148110 created "2018-05-17" @default.
• W2801148110 creator A5032754184 @default.
• W2801148110 creator A5059575648 @default.
• W2801148110 creator A5063063647 @default.
• W2801148110 creator A5069502224 @default.
• W2801148110 date "2018-05-07" @default.
• W2801148110 modified "2023-10-01" @default.
• W2801148110 title "A clinical follow-up of omalizumab in routine treatment of allergic asthma monitored by CD-sens" @default.
• W2801148110 cites W1491928602 @default.
• W2801148110 cites W1571982287 @default.
• W2801148110 cites W1964136976 @default.
• W2801148110 cites W1982630532 @default.
• W2801148110 cites W1985824732 @default.
• W2801148110 cites W1985951914 @default.
• W2801148110 cites W1986547754 @default.
• W2801148110 cites W2012158447 @default.
• W2801148110 cites W2012682704 @default.
• W2801148110 cites W2019947521 @default.
• W2801148110 cites W2034499139 @default.
• W2801148110 cites W2047184954 @default.
• W2801148110 cites W2055220989 @default.
• W2801148110 cites W2072902367 @default.
• W2801148110 cites W2084370208 @default.
• W2801148110 cites W2097981132 @default.
• W2801148110 cites W2111609315 @default.
• W2801148110 cites W2125078269 @default.
• W2801148110 cites W2126699286 @default.
• W2801148110 cites W2128553167 @default.
• W2801148110 cites W2129649074 @default.
• W2801148110 cites W2146384139 @default.
• W2801148110 cites W2156916462 @default.
• W2801148110 cites W2553844028 @default.
• W2801148110 cites W2591224895 @default.
• W2801148110 cites W2601782539 @default.
• W2801148110 cites W2606779794 @default.
• W2801148110 cites W2613362962 @default.
• W2801148110 cites W2616336702 @default.
• W2801148110 cites W4211006694 @default.
• W2801148110 doi "https://doi.org/10.1002/iid3.225" @default.
• W2801148110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6113766" @default.
• W2801148110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29737044" @default.
• W2801148110 hasPublicationYear "2018" @default.
• W2801148110 type Work @default.
• W2801148110 sameAs 2801148110 @default.
• W2801148110 citedByCount "8" @default.
• W2801148110 countsByYear W28011481102018 @default.
• W2801148110 countsByYear W28011481102019 @default.
• W2801148110 countsByYear W28011481102021 @default.
• W2801148110 countsByYear W28011481102022 @default.
• W2801148110 countsByYear W28011481102023 @default.
• W2801148110 crossrefType "journal-article" @default.
• W2801148110 hasAuthorship W2801148110A5032754184 @default.
• W2801148110 hasAuthorship W2801148110A5059575648 @default.
• W2801148110 hasAuthorship W2801148110A5063063647 @default.
• W2801148110 hasAuthorship W2801148110A5069502224 @default.
• W2801148110 hasBestOaLocation W28011481101 @default.
• W2801148110 hasConcept C126322002 @default.
• W2801148110 hasConcept C141105273 @default.
• W2801148110 hasConcept C159654299 @default.
• W2801148110 hasConcept C203014093 @default.
• W2801148110 hasConcept C207480886 @default.
• W2801148110 hasConcept C2776042228 @default.
• W2801148110 hasConcept C2778564945 @default.
• W2801148110 hasConcept C2780333948 @default.
• W2801148110 hasConcept C2780510475 @default.
• W2801148110 hasConcept C3020633164 @default.
• W2801148110 hasConcept C71924100 @default.
• W2801148110 hasConcept C90924648 @default.
• W2801148110 hasConceptScore W2801148110C126322002 @default.
• W2801148110 hasConceptScore W2801148110C141105273 @default.
• W2801148110 hasConceptScore W2801148110C159654299 @default.
• W2801148110 hasConceptScore W2801148110C203014093 @default.
• W2801148110 hasConceptScore W2801148110C207480886 @default.
• W2801148110 hasConceptScore W2801148110C2776042228 @default.
• W2801148110 hasConceptScore W2801148110C2778564945 @default.
• W2801148110 hasConceptScore W2801148110C2780333948 @default.
• W2801148110 hasConceptScore W2801148110C2780510475 @default.
• W2801148110 hasConceptScore W2801148110C3020633164 @default.
• W2801148110 hasConceptScore W2801148110C71924100 @default.
• W2801148110 hasConceptScore W2801148110C90924648 @default.
• W2801148110 hasIssue "3" @default.
• W2801148110 hasLocation W28011481101 @default.
• W2801148110 hasLocation W28011481102 @default.
• W2801148110 hasLocation W28011481103 @default.
• W2801148110 hasLocation W28011481104 @default.
• W2801148110 hasOpenAccess W2801148110 @default.
• W2801148110 hasPrimaryLocation W28011481101 @default.
• W2801148110 hasRelatedWork W2014471812 @default.
• W2801148110 hasRelatedWork W2037019085 @default.
• W2801148110 hasRelatedWork W2054114633 @default.
• W2801148110 hasRelatedWork W2129149137 @default.
• W2801148110 hasRelatedWork W2145013427 @default.
• W2801148110 hasRelatedWork W2170347784 @default.
• W2801148110 hasRelatedWork W2266295269 @default.
• W2801148110 hasRelatedWork W2576763337 @default.
• W2801148110 hasRelatedWork W30803436 @default.
• W2801148110 hasRelatedWork W4283364380 @default.

• next